We leverage AI to design novel chemical syntheses within seconds.

Sunfish Partners

Possible Ventures

Cherubic Ventures

Inventures

Expeditions Fund

Firlej Kastory

Outsized Ventures

AME Cloud Ventures

Atmos Ventures

Sebastian Guth

Molecule.one

As 2023 slowly comes to a conclusion, we would like to wish you a Merry Christmas and Happy Holidays, filled with warmth and love.

May the new year be kind and full of good moments for all of you!

Molecule.one team

Exciting news! 
The Molecule.one team is heading to #NeurIPS 2023 in New Orleans, a leading annual conference in the field of machine learning and artificial intelligence.

Our team (Mikołaj Sacha, Piotr Kozakowski, Michał Sadowski, Jan Busz) will be presenting “Molecule-Edit Templates for Efficient and Accurate Retrosynthesis Prediction” at two workshops:

➡ ML4Molecules:
📅 December 8, 2023
Online: https://lnkd.in/gUN8GVDs

➡ AI4Science:
📅 December 16, 2023
In-person: https://lnkd.in/gtuYTDCh

Hope to see you there! 
#NeurIPS2023 #ML4Molecules #AI4Science

Looking forward to our workshop at ML in PL on de novo drug discovery, run together between Molecule.one, insitro and GMUM - Group of Machine Learning Research! 🧑‍🔬 

❗ JOB OFFER ❗ 

Molecule.one is hiring for a Machine Learning Internship. Join us on our journey to solve the unpredictability of chemistry by harnessing the power of LLMs! See attached link for more information.

How to apply: via email to ai.recruitment@molecule.one
Deadline: 3 November

Molecule.one is a tech-bio company based in Warsaw, Poland, focused on solving the unpredictability of organic chemistry to accelerate drug discovery. The company leverages expertise in organic chemistry, artificial intelligence, and software to empower chemists and improve drug synthesis processes.

ONE:MOLECULE

Molecule.one

Filings Not Available